Identification of Tamoxifen−DNA Adducts Formed by α-Sulfate Tamoxifen and α-Acetoxytamoxifen
- 1 February 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 10 (2) , 189-196
- https://doi.org/10.1021/tx960114h
Abstract
α-Sulfate trans-tamoxifen and α-sulfate cis-tamoxifen were synthesized as proposed active metabolites of tamoxifen that react with DNA. α-Acetoxytamoxifen was prepared as a model-activated form to produce a reactive carbocation. Calf thymus DNA was reacted with α-hydroxytamoxifen or the activated forms of tamoxifen, and tamoxifen−DNA adducts were analyzed by a 32P-postlabeling method. The reactivity of α-sulfate trans-tamoxifen to DNA was much higher than that of α-hydroxytamoxifen. The formation of tamoxifen−DNA adducts induced by α-acetoxytamoxifen and α-sulfate cis-tamoxifen was 1100- and 1600-fold, respectively, higher than that of α-hydroxytamoxifen. Both α-sulfate tamoxifens and α-acetoxytamoxifen were highly reactive to 2‘-deoxyguanosine. Four reaction products of dG-tamoxifen were isolated by HPLC and characterized by mass- and proton magnetic resonance spectroscopy. Fractions 1 and 2 that eluted first were identified as the epimers of trans form of dG-N2-tamoxifen. Fractions 3 and 4 were identified as the epimers of cis form of dG-N2-tamoxifen. When DNA was reacted with α-acetoxytamoxifen in vitro, three isomers of dG-N2-tamoxifen were detected: fraction 2 was the major adduct while fractions 1 and 3 were minor adducts.Keywords
This publication has 3 references indexed in Scilit:
- Tamoxifen: evidence by 32P–postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4–hydroxytamoxifen as a proximate metaboliteCarcinogenesis: Integrative Cancer Research, 1994
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991